Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Kim, Sol ^a   Joo, Dong Hyun ^b   Lee, Jee Boong ^a   Shim, Byoung Shik ^b   Cheon, In Su ^b   Jang, Ji Eun ^b   Song, Ho Hyun ^b   Kim, Kyung Hyo ^c   Song, Man Ki ^b   Chang, Jun ^a  

^a Ewha Womans University   (South Korea)

^b International Vaccine Institute   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIGEN; GCF VACCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; EPITOPE; GLYCOPROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CHEMOTAXIS; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; LUNG LAVAGE; LYMPHOCYTE; METABOLISM; METHODOLOGY; MUCOSAL IMMUNITY;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRONCHOALVEOLAR LAVAGE; CHEMOTAXIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOCYTES; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84863297327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032226     Document Type: Article

References (40)

1. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB, (2000) Impact of respiratory virus infections on persons with chronic underlying conditions. Jama 283: 499-505.
2. Han LL, Alexander JP, Anderson LJ, (1999) Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 179: 25-30.
3. Falsey AR, (1998) Respiratory syncytial virus infection in older persons. Vaccine 16: 1775-1778.
4. Levine S, Klaiber-Franco R, Paradiso PR, (1987) Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 68 (Pt 9): 2521-2524.
5. Taylor G, Stott EJ, Bew M, Fernie BF, Cote PJ, et al. (1984) Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52: 137-142.
6. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, et al. (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2: 732-738.
7. Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, et al. (1998) Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J Virol 72: 2871-2880.
8. Openshaw PJ, Clarke SL, Record FM, (1992) Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol 4: 493-500.
9. Hancock GE, Speelman DJ, Heers K, Bortell E, Smith J, et al. (1996) Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J Virol 70: 7783-7791.
10. Tebbey PW, Hagen M, Hancock GE, (1998) Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J Exp Med 188: 1967-1972.
11. Sparer TE, Matthews S, Hussell T, Rae AJ, Garcia-Barreno B, et al. (1998) Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med 187: 1921-1926.
12. Yu JR, Kim S, Lee JB, Chang J, (2008) Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J Virol 82: 2350-2357.
13. Lemiale F, Kong WP, Akyurek LM, Ling X, Huang Y, et al. (2003) Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 77: 10078-10087.
14. Armstrong ME, Lavelle EC, Loscher CE, Lynch MA, Mills KH, (2005) Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines. J Infect Dis 192: 1628-1633.
15. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, et al. (2007) Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 120: 707-713.
16. Akdis M, (2008) Immunologic responses to sublingual allergen immunotherapy. Clin Allergy Immunol 21: 71-86.
17. Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, et al. (2007) Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25: 8598-8610.
18. Martinez I, Dopazo J, Melero JA, (1997) Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78 (Pt 10): 2419-2429.
19. Martinez I, Melero JA, (1998) Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein. J Gen Virol 79 (Pt 9): 2215-2220.
20. Brandtzaeg P, (2003) Role of secretory antibodies in the defence against infections. Int J Med Microbiol 293: 3-15.
21. Srikiatkhachorn A, Braciale TJ, (1997) Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med 186: 421-432.
22. Alwan WH, Kozlowska WJ, Openshaw PJ, (1994) Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 179: 81-89.
23. Stevens WW, Kim TS, Pujanauski LM, Hao X, Braciale TJ, (2007) Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J Immunol Methods 327: 63-74.
24. Carretero-Ortega J, Walsh CT, Hernandez-Garcia R, Reyes-Cruz G, Brown JH, et al. (2010) Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide exchange factor for Rac, mediates angiogenic responses to stromal cell-derived factor-1/chemokine stromal cell derived factor-1 (SDF-1/CXCL-12) linked to Rac activation, endothelial cell migration, and in vitro angiogenesis. Mol Pharmacol 77: 435-442.
25. van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR, (2000) Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165: 4778-4782.
26. Fujihashi K, Koga T, van Ginkel FW, Hagiwara Y, McGhee JR, (2002) A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 20: 2431-2438.
27. Yamamoto S, Kiyono H, Yamamoto M, Imaoka K, Fujihashi K, et al. (1997) A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci U S A 94: 5267-5272.
28. Gorman JJ, Ferguson BL, Speelman D, Mills J, (1997) Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci 6: 1308-1315.
29. Plotnicky-Gilquin H, Goetsch L, Huss T, Champion T, Beck A, et al. (1999) Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein. J Virol 73: 5637-5645.
30. Power UF, Plotnicky-Gilquin H, Huss T, Robert A, Trudel M, et al. (1997) Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology 230: 155-166.
31. Power UF, Plotnicky H, Blaecke A, Nguyen TN, (2003) The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B. Vaccine 22: 168-176.
32. Johnson PR Jr, Olmsted RA, Prince GA, Murphy BR, Alling DW, et al. (1987) Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol 61: 3163-3166.
33. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, et al. (2010) CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 107: 14745-14750.
34. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
35. Harcourt J, Alvarez R, Jones LP, Henderson C, Anderson LJ, et al. (2006) Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol 176: 1600-1608.
36. Witt DP, Lander AD, (1994) Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 4: 394-400.
37. Feldman SA, Hendry RM, Beeler JA, (1999) Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 73: 6610-6617.
38. Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, et al. Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol 84: 1148-1157.
39. Huang Y, Cyr SL, Burt DS, Anderson R, (2009) Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine. Journal of Clinical Virology 44: 287-291.
40. Kammann M, Laufs J, Schell J, Gronenborn B, (1989) Rapid insertional mutagenesis of DNA by polymerase chain reaction (PCR). Nucleic Acids Res 17: 5404.